【24h】

Implantable parylene MEMS for glaucoma therapy

机译:用于青光眼疗法的植入二烯烯啉Mems

获取原文

摘要

An implantable glaucoma management system is presented for the first time. Glaucoma is an incurable disease characterized by gradual visual field loss that eventually results in blindness. Studies indicate that reduction of intraocular pressure reduces the rate of disease progress. A passive parylene MEMS pressure sensor and drainage shunt comprise a complete system for the detection and alleviation of elevated intraocular pressure. Tissue anchors for securing the pressure sensor to the iris have been developed to facilitate direct and convenient optical monitoring of intraocular pressure.
机译:植入的青光眼管理系统是第一次提出的。青光眼是一种可治区疾病,其特征在于逐步的视野损失,最终导致失明。研究表明,降低眼压的降低降低了疾病进展速率。无源聚偶烯MEMS压力传感器和排水分流器包括用于检测和减轻升高的眼内压力的完整系统。已经开发了用于将压力传感器固定到光圈的组织锚,以便于直接和方便的眼内压力监测。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号